AGP Picks
View all

Tech Times of New York
Provided by AGP

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 30, 2026

Streamex Co-Founder Morgan Lekstrom to Transition to Independent Director
Sep. 30, 2026

Streamex Co-Founder Morgan Lekstrom to Transition to Independent Director

Indeterminate GlobeNewswire
Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th
Sep. 30, 2026

Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th

Indeterminate GlobeNewswire
Wintrust Financial Corporation Announces Third Quarter and Year-to-Date 2026 Earnings Release Schedule
Sep. 30, 2026

Wintrust Financial Corporation Announces Third Quarter and Year-to-Date 2026 Earnings Release Schedule

Indeterminate GlobeNewswire
Richardson Electronics Announces Date of First Quarter Fiscal Year 2027 Conference Call
Sep. 30, 2026

Richardson Electronics Announces Date of First Quarter Fiscal Year 2027 Conference Call

Indeterminate GlobeNewswire
Halper Sadeh LLC is Investigating Whether LFCR, MKTX, UTZ are Obtaining Fair Deals for their Shareholders
Sep. 30, 2026

Halper Sadeh LLC is Investigating Whether LFCR, MKTX, UTZ are Obtaining Fair Deals for their Shareholders

Indeterminate GlobeNewswire
Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer
Sep. 30, 2026

Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire
$HAREHOLDER ALERT - The M&A Class Action Firm Continues to Investigate the Merger— ATKR, BZH, BGMS and CBAN
Sep. 30, 2026

$HAREHOLDER ALERT - The M&A Class Action Firm Continues to Investigate the Merger— ATKR, BZH, BGMS and CBAN

Indeterminate GlobeNewswire
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Sep. 30, 2026

Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire
Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026
Sep. 30, 2026

Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire
Progress Software Reports Fiscal Third Quarter 2026 Financial Results
Sep. 30, 2026

Progress Software Reports Fiscal Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Longeveron to Participate in Three Longevity/Aging Investment Conferences
Sep. 30, 2026

Longeveron to Participate in Three Longevity/Aging Investment Conferences

Indeterminate GlobeNewswire
Atsena Presents Positive 18-Month Results from Part A of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
Sep. 30, 2026

Atsena Presents Positive 18-Month Results from Part A of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire
Medallion Bank Announces Closing of Series G Preferred Stock Offering
Sep. 30, 2026

Medallion Bank Announces Closing of Series G Preferred Stock Offering

Indeterminate GlobeNewswire
Scienture Holdings, Inc. Announces Reverse Stock Split
Sep. 30, 2026

Scienture Holdings, Inc. Announces Reverse Stock Split

Indeterminate GlobeNewswire
Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
Sep. 30, 2026

Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa

Indeterminate GlobeNewswire
FormFactor Announces Participation in 18th Annual CEO Investor Summit 2026
Sep. 30, 2026

FormFactor Announces Participation in 18th Annual CEO Investor Summit 2026

Indeterminate GlobeNewswire
Bank OZK Announces Third Quarter 2026 Earnings Release and Conference Call Dates
Sep. 30, 2026

Bank OZK Announces Third Quarter 2026 Earnings Release and Conference Call Dates

Indeterminate GlobeNewswire
Micron Technology, Inc. Reports Record Fiscal Fourth-Quarter and Full-Year 2026 Results
Sep. 30, 2026

Micron Technology, Inc. Reports Record Fiscal Fourth-Quarter and Full-Year 2026 Results

Indeterminate GlobeNewswire
Arhaus Announces K.C. Moss as Chief Digital Officer
Sep. 30, 2026

Arhaus Announces K.C. Moss as Chief Digital Officer

Indeterminate GlobeNewswire
Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk
Sep. 30, 2026

Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.